Hosoki S, Takagi M, Yamagami H, Ando D, Toyoda K, Koga M. Paradoxical elevation of plasma dabigatran after reversal with idarucizumab in stroke thrombolysis. Journal of neurology. 2018. 265. 10. 2451-2453
The Bleeding with Antithrombotic Therapy Study 2 (BAT2): Study protocol and baseline clinical characteristics of initial 1500 participants.
The Bleeding with Antithrombotic Therapy Study 2 (BAT2): Study protocol and demographic characteristics of initial 1000 participants
(the 8th Korea-Japan Joint Stroke Conference)